Skip to main content
Premium Trial:

Request an Annual Quote

New Products: NanoInk’s NanoArray Assay System and More

Premium

NanoInk this week released its new NanoArray Assay System for the automated analysis of its protein NanoArray assays.

The system is intended for detection, identification, and quantitation of proteins for applications including biomarker analysis, translational medicine, and toxicology. The automated Assay System brings additional precision and higher throughput to NanoArray assays, the company said.


Promega this week introduced four new proteases – Pepsin, Elastase, Sequencing Grade Arg-C, and Thermolysin – for mass spec protein sample prep.

The proteases are provided in a lyophilized format and are intended for use for peptide mapping, protein identification, and characterization of post-translational modifications.


Epitomics this week announced the release of new rabbit monoclonal antibodies including ACAA2, MVD, OVOL2, and CD63.

Each antibody is validated in multiple applications and in multiple species including human, mouse, and rat.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.